- Meeting abstract
- Open Access
Integration sites of the HTLV-1 provirus in host human genome in the IDH patients with monoclonal integration
© Argolo et al; licensee BioMed Central Ltd. 2011
- Published: 6 June 2011
- Flower Cell
- Integration Site
- Transcriptional Start Site
- Peripheral Blood Smear
Infective dermatitis associated with HTLV-1 (IDH) is a recurrent and severe childhood infected form of eczema, that usually begins at 18 months in vertically-infected children. IDH may progress to adult T-cell leukemia/lymphoma (ATL). Abnormal T cells (ably), including flower cells, were found in the peripheral blood smears of 30% (9/31) of IDH patients in Bahia, Brazil. Monoclonal integration of provirus assessed by inverted long PCR (ILPCR) was detected in 3 of these patients (2 with flower cells and one with ably cells but without flower cells in peripheral blood smear). The aim of this study was to identify the integration sites of the HTLV-1 provirus in host human genome in the IDH patients with monoclonal integration
The sequences of the PCR products of these 3 patients obtained by ILPCR were mapped on to the human genome using the Basic Local Alignment Search Tool http://www.ncbi.nih.gov/blast.cgi.
In the two patients with flower cells, integration sites were detected, respectively, in chromosome 1 (1p34.2) and chromosome 3 (3p11.1). In chromosome 1, the provirus was located within PPM1H gene coding region and in chromosome 3, within alpha satellite DNA sequences. The patient with integration in chromosome 1 also presents HAM/TSP. In the IDH patient without flower cells, integration site was identified at chromosome 12 (12q14) and was located near the transcriptional start site of GUCA2B gene.
In IDH patients with monoclonal integration, the provirus integration sites can be associated with transcriptionally active regions of the human host genome.
This article is published under license to BioMed Central Ltd. This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.